secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000950170-23-000395
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences reports preliminary cash of $276.6M and 68.5M shares outstanding as of Dec 31, 2022
--------------------------------------------------------------------------------

- Preliminary cash, cash equivalents and marketable securities of ~$276.6M as of Dec 31, 2022.
- Approximately 68.5 million shares of common stock outstanding as of year-end 2022.
- Estimates are unaudited and subject to change upon completion of year-end closing procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017023000395/0000950170-23-000395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017023000395/kzr-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer